![AACR – Broadening eligibility criteria for cancer clinical trials may better demonstrate how a drug will affect a real-world population](https://oncodaily.com/pub/uploads/2024/08/aacr.jpeg)
Photo taken from AACR/LinkedIn
Aug 21, 2024, 13:57
AACR – Broadening eligibility criteria for cancer clinical trials may better demonstrate how a drug will affect a real-world population
American Association for Cancer Research shared on LinkedIn:
“Broadening eligibility criteria for cancer clinical trials allows more patients to participate and may better demonstrate how a drug will affect a real-world population. Data from a recent study published in the AACR journal Clinical Cancer Research and new efforts from the FDA may help clinical researchers do this safely.”
Read further.
Source: AACR/LinkedIn